Stem cell injection for sudden severe hearing loss
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This trial tests a new treatment for sudden, severe hearing loss that hasn't improved with standard care. A single injection of stem cell particles is given into the ear to see if it safely restores hearing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have sudden hearing loss in one ear that started within the last 3 days
- Your hearing loss is severe or profound (65 decibels or more) in at least 3 frequencies
- You are between 18 and 65 years old
- You have not received any other treatment for this hearing loss yet
- You can come for regular follow-up visits and exams
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to deliver steroid medication directly into the inner ear through the eardrum to treat sudden hearing loss in one ear. The goal is to help restore hearing after standard treatments haven't fully worked.
This trial tests a regenerative stem cell treatment for people with hearing loss, tinnitus, or inner ear injury. It aims to see if the therapy can improve hearing or reduce symptoms.
This study tests whether a medication called hydroxychloroquine, usually used for malaria or autoimmune conditions, can help treat sudden hearing loss. It will be compared to standard steroid treatment. The goal is to see if it improves hearing recovery.
This trial tests a combination of treatments (integrative medicine) for people who have just lost their hearing suddenly. It may help improve hearing recovery if started early.
This trial is for adults who develop sudden hearing loss over a very short time window, confirmed by a hearing test. It aims to study the sudden hearing loss condition and whether the study approach can help people recover hearing.
This study tests whether a nasal spray containing tiny particles from donated stem cells can help people recover from a recent ischemic stroke. The treatment is given as a nose spray, and you will be monitored for up to 14 days after your stroke.
Hear when a new Sudden Hearing Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.